Related Experiment Videos
Thrombin activity and oral anticoagulant therapy: a preliminary study
F Marongiu1, G G Sorano, G Mameli
1Institute of Internal Medicine, University of Cagliari, Italy.
Haemostasis
|January 1, 1989
Summary
This study found a strong link between oral anticoagulant therapy effectiveness and thrombin activity. Deep anticoagulation is necessary to significantly reduce thrombin levels.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Oral anticoagulants are crucial for preventing thromboembolic events.
- Monitoring anticoagulation efficacy is essential for patient safety.
- Thrombin activity is a key marker in the coagulation cascade.
Purpose of the Study:
- To investigate the relationship between thrombin activity and the degree of anticoagulation.
- To identify an optimal anticoagulation range for minimizing thrombin activity.
Main Methods:
- Studied 28 patients on long-term acenocoumarol therapy.
- Monitored anticoagulation using the thrombotest method (therapeutic range 5-13%).
- Measured thrombin activity via fibrinopeptide A (FPA) radioimmunoassay and analyzed data using polynomial regression.
Main Results:
- A significant positive correlation was observed between thrombotest results and FPA levels (p < 0.001).
- Polynomial regression analysis revealed a steeper curve in thrombin activity beyond 10% thrombotest.
- Significantly lower FPA levels were found in the 14-25% and 11-13% thrombotest ranges compared to the 4-10% range.
Conclusions:
- Thrombin activity is directly related to the degree of anticoagulation achieved with oral anticoagulants.
- A deep level of anticoagulation is required to achieve a significant reduction in thrombin activity.